Blog: Weekly Stem Cell Series: Part 3 - What are Induced Pluripotent Stem Cells (iPSCs) and How is Sendai Virus used to Generate iPSCs?
In the last blog post of this weekly series we talked about the different types of pluripotent stem cells, let’s talk more about induced pluripotent stem cells and how to create them.Read More
Blog: New Webinar: Plant Genome Engineering - Three Sessions October 9th-11th
This webinar presented by Dr. Jon Chesnut, Research Fellow at Life Technologies, will introduce the latest genome editing technology for plants and explain available cloning and algae engineering tools.Read More
Blog: Life Technologies Food Safety Efforts At The 2012 Olympic Games
Watch a video showing Life Technologies efforts to help ensure the quality and safety of food being served to athletes and visitors of the 2012 Olympic Games.Read More
Blog: Life Technologies Takes a Creative Approach to Hiring Finance Graduates
Life Technologies has found a creative approach to hiring and molding finance professionals - the Financial Leadership Development Program, or FLDP. The program targets...Read More
Blog: FDA Clears Life Technologies’ OpTmizer™ T-Cell Growth Medium for Use in Clinical Trials
Life Technologies has received FDA 510(k) clearance for its OpTmizer™ CTS™ T-Cell Expansion Tissue Culture Medium – a reagent that is now cleared as a Class II medical device and offers cost- and time-saving advantages for transitioning studies from the research bench to clinical trials.Read More
Blog: What is Essential 8™ Medium and How do I Adapt my Pluripotent Stem Cell Cultures to Essential 8™?
In this weekly series, we’re exploring some frequently asked questions about stem cells and our products for stem cell research. In this second installment we'll show you Essential 8™ Medium.Read More
Blog: Will you be Attending the 38th Annual ASHI Meeting?
While you're attending the 38th Annual ASHI Meeting, don't miss Life Technologies at booth #501. We will be showcasing the HLA sequence-based typing workflow.Read More
Blog: Life Technologies Launches Pervenio™ Lung RS, a Risk Stratification Test for Early Stage Lung Cancer
Today Life Technologies announced the launch of Pervenio™ Lung RS. First-of-its-kind, the molecular test has been documented to reliably identify early stage lung cancer patients who are at high risk for mortality following surgery. It also fulfills an unmet need for prognostic information to guide preventative treatment and improve disease management. Read More
Blog: Somatic Mutations Have Nowhere to Hide
Tomorrow Life Technologies will be offering a live free webinar about castPCR™ technology used by our TaqMan Mutation Detection Assays. Read More
Blog: Stem Cell FAQ: What are Pluripotent Stem Cells, How to Maintain Them and Using Essential 8™ Medium
This week, we start with the basics. What are Pluripotent Stem Cells, how to maintain them and culturing with Essential 8™ Medium. Read More